학술논문

Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial
Document Type
Article
Source
In: American Journal of Kidney Diseases. (American Journal of Kidney Diseases, May 2023, 81(5):517-527.e1)
Subject
Language
English
ISSN
15236838
02726386